ISEE

IVERIC bio, Inc. Common Stock

Delisted

ISEE was delisted on the 10th of July, 2023.

223 hedge funds and large institutions have $3.58B invested in IVERIC bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 85 increasing their positions, 78 reducing their positions, and 35 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
223
Holders Change
-2
Holders Change %
-0.89%
% of All Funds
3.57%
Holding in Top 10
15
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-21.05%
% of All Funds
0.24%
New
36
Increased
85
Reduced
78
Closed
35
Calls
$59.3M
Puts
$49.2M
Net Calls
+$10M
Net Calls Change
+$440K
Name Holding Trade Value Shares
Change
Shares
Change %
PHS
26
PFM Health Sciences
California
$35.7M +$13.3M +547,926 +60%
Dimensional Fund Advisors
27
Dimensional Fund Advisors
Texas
$33.7M -$1.16M -47,742 -3%
PCH
28
Polar Capital Holdings
United Kingdom
$33.1M -$12.3M -506,627 -27%
Northern Trust
29
Northern Trust
Illinois
$31.7M +$947K +38,920 +3%
Deutsche Bank
30
Deutsche Bank
Germany
$31.2M -$27.9M -1,148,521 -47%
Ameriprise
31
Ameriprise
Minnesota
$30.2M +$3.65M +150,021 +14%
Millennium Management
32
Millennium Management
New York
$30.2M -$22.7M -931,236 -43%
Balyasny Asset Management
33
Balyasny Asset Management
Illinois
$29.3M +$8.74M +359,422 +43%
Nuveen Asset Management
34
Nuveen Asset Management
Illinois
$28.9M -$9M -369,955 -24%
KCM
35
Kingdon Capital Management
New York
$25.6M +$4.87M +200,000 +23%
MB
36
MPM BioImpact
Massachusetts
$25.4M -$341K -13,997 -1%
Goldman Sachs
37
Goldman Sachs
New York
$24.2M -$6.84M -280,962 -22%
Charles Schwab
38
Charles Schwab
California
$23.8M +$319K +13,093 +1%
SI
39
Sofinnova Investments
California
$22M +$6.51M +267,584 +42%
CS
40
Candriam SCA
Luxembourg
$20.8M -$4.59M -204,902 -18%
Morgan Stanley
41
Morgan Stanley
New York
$20.2M +$9.69M +398,083 +92%
BC
42
Boxer Capital
California
$20.1M
Skandinaviska Enskilda Banken (SEB)
43
Skandinaviska Enskilda Banken (SEB)
Sweden
$19.1M -$152K -6,260 -0.8%
JPMorgan Chase & Co
44
JPMorgan Chase & Co
New York
$19M +$2.02M +83,003 +12%
EA
45
Emerald Advisers
Pennsylvania
$18.3M -$146K -6,012 -0.8%
FC
46
Finepoint Capital
Massachusetts
$17.6M +$389K +16,000 +2%
TCM
47
TimesSquare Capital Management
New York
$17.5M -$7.1M -291,815 -29%
Barclays
48
Barclays
United Kingdom
$17.5M +$11.8M +483,518 +206%
GPP
49
Great Point Partners
Connecticut
$16.9M -$3.19M -130,991 -16%
SB
50
Samsara BioCapital
California
$16.7M -$2.95M -121,206 -15%